Skip to main content
OpenTrials
Completed

NCT Number: NCT00551863

Developing Violence Prevention Therapy for Substance Abusers

The purpose of this project is to develop and pilot test a violence prevention intervention for men and women in treatment for substance use problems.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

University of Michigan

Ann Arbor, Michigan, 48105, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of substance use related problems
  • Interpersonal Violence history in the year before recruitment

Exclusion criteria

  • Primary opiate dependence
  • Presence of active psychotic disorder
  • < 18 years of age

Treatment and study plan

IVPT

Behavioral

Violence prevention intervention based on Motivational Interviewing and CBT

Primary outcomes

  1. Interpersonal Violence

    Time frame: 3 and 6 month follow-up

Secondary outcomes

  1. alcohol and drug use

    Time frame: 3 and 6 month follow-up

Sponsors and collaborators

Lead sponsor

University of Michigan

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Development of Violence Therapy for Substance Abusers

Important dates

Study start
2004
Primary completion
2008
Study completion
2008
First posted
Oct 31, 2007
Registry last updated
Aug 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.